He was Pres of “Hema” until 2017 or 18. In subsequent Generex press releases dating back to then it was Haines as President. I assume it’s still Haines for NuGenerex Diagnostics that isn’t known to be involved in a Covid rapid test. Generex as Joe discussed in the CC had to devote all funds to the vaccines (AE37 Keytruda and Ii-Key Covid). The Ii-Key Covid vaccine already brought in more money via licensing than Hema ever did in their history so I’m happy with that choice as shareholder. After Generex is fully funded the other programs and subsidiaries come back into the picture.